Taha Farouk Shehata Ali
11PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Oct 29, 2025
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent Advances.Mohamed A S Badawy, Stefan Bräse, Taha F S Ali
|May 25, 2024
Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor.Aya Soudi, Onur Bender, Ismail Celik
|Jul 14, 2023
Combination of an Oxindole Derivative with (-)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells.Jowaher Alanazi, Onur Bender, Rumeysa Dogan
|May 14, 2022
Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell Migration.Tsugumasa Toma, Hiroshi Tateishi, Kensaku Kawakami
|Apr 23, 2022
Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity.Taha F S Ali, Halil I Ciftci, Mohamed O Radwan
|Nov 27, 2021
New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors.Momen R Fareed, Mai E Shoman, Mohammed I A Hamed
Pageof 2
Frequent Collaborators
2 joint publications
Arzu Atalay
2 joint publications
Onur Bender
2 joint publications
Hiroshi Tateishi
2 joint publications
Mohamed O Radwan
2 joint publications
Halil I Ciftci
2 joint publications
Mikako Fujita
2 joint publications
Ahmed M Shawky
1 joint publications
Mehlika Dilek Altıntop
1 joint publications
Doha E Ellakwa
1 joint publications
Mahmoud A A Ibrahim
